HR 1060 United States House · 119th Congress

Modern Authentication of Pharmaceuticals Act of 2025

This bill requires manufacturers to include a unique physical or chemical identifier on each pill of certain controlled substances in solid oral dosage form (like tablets or capsules). It directly affects pharmaceutical companies producing these specific medications, mandating the identifier to be added to every dose manufactured five years after the bill's enactment. The identifier must be machine-readable and help verify the product's authenticity throughout the supply chain. This change aims to improve tracking and combat counterfeit drugs in the distribution system.
Bill status in committee 1 of 4 stages cleared
Introduction
Feb 2025
Committee Review
Floor Vote
President
Introduced Feb 6, 2025 Last action Feb 6, 2025
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
0
Committee
1
Feb 6, 2025
Committee
Referred to the House Committee on Energy and Commerce.
lower
Feb 6, 2025
Introduced
Introduced in House
lower
1 primary · 3 co-sponsors

Sponsors